KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scotts Miracle-Gro (SMG) Cash & Equivalents (2016 - 2025)

Scotts Miracle-Gro's Cash & Equivalents history spans 17 years, with the latest figure at $8.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 45.61% year-over-year to $8.3 million; the TTM value through Dec 2025 reached $8.3 million, up 45.61%, while the annual FY2025 figure was $32.8 million, 54.19% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $8.3 million at Scotts Miracle-Gro, down from $32.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $279.9 million in Q2 2024 and bottomed at $5.7 million in Q4 2024.
  • The 5-year median for Cash & Equivalents is $27.4 million (2023), against an average of $54.2 million.
  • The largest annual shift saw Cash & Equivalents soared 1370.48% in 2021 before it crashed 81.74% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $244.1 million in 2021, then crashed by 89.51% to $25.6 million in 2022, then tumbled by 59.38% to $10.4 million in 2023, then crashed by 45.19% to $5.7 million in 2024, then surged by 45.61% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for SMG's Cash & Equivalents are $8.3 million (Q4 2025), $32.8 million (Q3 2025), and $51.1 million (Q2 2025).